$SLXP Recent Headlines ‘Inversion’ payoff for

New Post Public Reply Private Reply Replies (0) Message Board

Aug 16, 2014 at 11:22 AM

$SLXP Recent Headlines

‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
Charting the approach of S&P 2,000 11:06 a.m. July 24, 2014 - Michael Ashbaugh
Another good find in specialty pharma 12:17 p.m. July 3, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Playing defense in a market in transition 3:08 p.m. April 29, 2014 - The Trading Deck
Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
2 leading growth stocks setting up for a move 2:29 p.m. Dec. 24, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 1:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 12:29 p.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 7:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 8:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 11:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 10:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 12:02 a.m. March 22, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 5:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 6:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 11:44 a.m. Oct. 7, 2011 - Michael Ashbaugh

Trouble For Synergy Pharmaceuticals Shorts With Pending SP-333 Trial Results 7:24 p.m. Aug. 15, 2014 - Seeking Alpha
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Watch For Today's Momo Momentum Stock: Salix Pharmaceuticals (SLXP) 10:17 a.m. Aug. 15, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ACT AGN GILD IRWD 9:00 a.m. Aug. 15, 2014 - InvestorPlace.com
Why Tax Inversions Won't Go Away 2:20 p.m. Aug. 13, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – INCY WST BIIB SLXP 1:45 p.m. Aug. 13, 2014 - InvestorPlace.com
Salix Pharmaceuticals, Ltd. (SLXP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 13, 2014 - Zacks.com
Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog 10:50 a.m. Aug. 12, 2014 - Zacks.com
Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog 9:20 a.m. Aug. 12, 2014 - Zacks.com
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 11:50 a.m. Aug. 11, 2014 - Zacks.com
Inversion Deals Are Costing The U.S. 8:58 a.m. Aug. 11, 2014 - Seeking Alpha
Leaders Actavis, Salix Trip Sell Signals 5:37 p.m. Aug. 8, 2014 - Investors Business Daily
Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog 4:10 p.m. Aug. 8, 2014 - Zacks.com
OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% - Tale of the Tape 9:39 a.m. Aug. 8, 2014 - Zacks.com
IGI, Laboratories (IG) Jumps: Stock Adds 6.7% in Session - Tale of the Tape 8:51 a.m. Aug. 8, 2014 - Zacks.com
Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results 8:19 a.m. Aug. 8, 2014 - benzinga.com
Sterne Agee Adjusts Estimates For Salix Pharmaceuticals 8:17 a.m. Aug. 8, 2014 - benzinga.com
Salix Pharmaceuticals' (SLXP) CEO Carolyn Logan on Q2 2014 Results - Earnings Call Transcript 8:10 p.m. Aug. 7, 2014 - Seeking Alpha
Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide 5:50 p.m. Aug. 7, 2014 - Investors Business Daily
Salix Pharmaceuticals (SLXP) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 7, 2014 - Seeking Alpha

Corporate Statements, Supplemental New Drug Application, Financial Result, and Technical Update - Research Reports on Allergan, Salix, Medivation, Valeant and AstraZeneca 9:20 a.m. Aug. 13, 2014 - PR Newswire - PRF
Salix Announces Important Topline Results for Microbiome, Culture & Susceptibility, and Key Secondary Efficacy Results for TARGET 3, Rifaximin IBS-D Repeat Treatment Study 2:01 p.m. Aug. 11, 2014 - BusinessWire - BZX
FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date for RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Reports 2Q2014 Results 4:02 p.m. Aug. 7, 2014 - BusinessWire - BZX
Lifshitz & Miller Law Firm Announces Investigation of Design Within Reach, Inc., Family Dollar Stores, Inc., GFI Group Inc., Intermountain Community Bancorp, Rockwood Holdings, Inc., and Salix Pharmaceuticals Ltd. 1:19 p.m. July 31, 2014 - PR Newswire - PRF
Salix Pharmaceuticals Announces 2Q2014 Financial Results Conference Call and Webcast 7:00 a.m. July 24, 2014 - BusinessWire - BZX
Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma 9:20 a.m. July 23, 2014 - PR Newswire - PRF
Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE) 1:00 a.m. July 17, 2014 - BusinessWire - BZX
Progenics Holds Conference Call This Morning on FDA Appeal Response Regarding Relistor(R) sNDA for Patients With Chronic Non-Cancer Pain 7:05 a.m. July 14, 2014 - GlobeNewswire
FDA Office of Drug Evaluation III Approves Salix’s Request that the FDA Approve the RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. July 14, 2014 - BusinessWire - BZX
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
SALIX PHARMACEUTICALS, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger 11:42 a.m. July 10, 2014 - PR Newswire - PRF
SALIX SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Merger between Salix and Cosmo Pharmaceuticals May be Unfair to Shareholders 11:30 a.m. July 10, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Salix Pharmaceuticals, Ltd. In Connection With The Proposed Sale Of The Company 6:10 p.m. July 9, 2014 - BusinessWire - BZX
SALIX ALERT: Proposed Sale of Salix Pharmaceuticals, Ltd. Being Investigated by Johnson & Weaver, LLP 1:32 p.m. July 9, 2014 - BusinessWire - BZX
Cadwalader Advising Salix Pharmaceuticals in its Combination with Cosmo Technologies to Form Salix Pharmaceuticals, plc 9:05 p.m. July 8, 2014 - BusinessWire - BZX
Salix Pharmaceuticals to Combine with Cosmo Technologies to Form Salix Pharmaceuticals, plc 5:00 p.m. July 8, 2014 - BusinessWire - BZX
Salix Announces Statistically Significant Primary Endpoint Result for TARGET 3 Evaluating the Efficacy and Safety of Repeat Treatment with Rifaximin 550mg in Subjects with Irritable Bowel Syndrome with Diarrhea 7:00 a.m. July 1, 2014 - BusinessWire - BZX
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Salix Pharmaceuticals to Host Investor Day on July 9, 2014 7:00 a.m. June 25, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bugsy Siegel's Cold Case: Museum Exhibit Revisits Unsolved Murder

Whoever thought sleuthing around organized crime’s dark corridors would land you inside Las Vegas' Mob Museum, tracing the cold case trail of none other than Bugsy Siegel? Yeah, the notorious mobster whose murder on June 20, 1947, has remained frozen in mystery like a stiff in cement shoes. Now, as we inch closer to the 80-year mark since Siegel was shot dead in Beverly...

Tech's Role in Shaping Tomorrow's Classroom: 2026 Insights

Schools at a Crossroads: Career Skills Take Center Stage The data's out, and boy, is it telling. Project Tomorrow's 23rd Annual Speak Up Report brings a bushel of insights—some you'd expect, some that'll knock your socks off. With over 95,000 K-12 folks raising their voices, this is no small potatoes look into modern education's heartbeat. Parents Crying Out for...

Celebrate Dr. David Neff's Healthcare Legacy

An Icon in Medicine and Innovation Dr. David R. Neff's recognition as a Pinnacle Lifetime Member marks a storied journey through medicine and healthcare innovation. Decades of Dedication to Patient Care For over 45 years, Neff carved out a niche in medicine that few can parallel. His overarching focus on infectious disease, cancer, and more represents a holistic approach...

Centrus Ships Centrifuges to Boost U.S. Uranium Capacity

A Surge in Centrifuge Production This ain't exactly the kind of news you read over a breakfast special, but it's a biggie if you're watching the energy sector. Centrus Energy (NYSE: LEU) has just fired up the engines on their uranium enrichment expansion, shipping the first lot of their brand-spankin'-new centrifuges from Tennessee to Ohio. From here, they're looking to...

Jay Group Expands to Houston with New Fulfillment Hub

Jay Group's Bold Move in the Logistics Arena In a no-holds-barred expansion, Jay Group's got themselves a brand new sprawling 250,000-square-foot fulfillment hub deep in the heart of Houston. Now, folks, this isn’t just another warehouse. We're talking a 3PL powerhouse that allows coast-to-coast delivery, hitting 90% of U.S. consumers in just a couple of days. If you're...

Quanta Services Reports Record Q3 2026 Earnings

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Quad Sees Marginal Gains Amid Industry Challenges

Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...

Thunderly Bags Davey Awards for Creative Franchise Videos

Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...

Cohere's CAD $7 Billion Raise Signals AI Power Shift

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

xTool X1: Redefining Laser Fabrication for Makers

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...